Centocor
New developments from Centocor described
Published in Medical Imaging Business Week, August 9th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Centocor.
Report 1: Findings presented today at Digestive Disease Week(R) 2007 (DDW), from long-term extensions of the ACT trials (Active Ulcerative Colitis 1 & 2) show that subjects with moderately to severely active ulcerative colitis who had responded to REMICADE(R) (infliximab) in the blinded phase of the trials maintained improvement in their clinical symptoms for up to two years.
The ACT extension trials were conducted in both the United States and Europe, under co-principle...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
More Articles from Medical Imaging Business Week
- Abdominal Aortic Aneurysm
Scientists at University of Texas release new data on abdominal aortic aneurysm - Abdominal Imaging
Studies from Sichuan University provide new data on abdominal imaging - Acute Cholecystitis
Reports from University of Miami highlight recent research in acute cholecystitis - Adenoma
Scientists at Indiana University, Division of Gastroenterology discuss research in adenoma - Alcoholism
New alcoholism research has been reported by A. Picard et al - Allergies
Findings from Cambridge University in allergies reported - More from this issue of Medical Imaging Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
